$NVCR
NovoCure Limited Ordinary Shares
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
$14.94
▼-6.16%-$0.980
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNovoCure Limited Ordinary Shares
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is NVCR down today? It is at $14.94 (-6.16%), and our scanner flagged it 46 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NVCR spikes, and full due diligence on NVCR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NVCR 46 times in the last 30 days. Create a free account to track $NVCR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NVCR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NVCR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystNovocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer, from the latest SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Danziger Asaf Director | Acquired (grant/award) | +268 | added <0.1% | 417K | $3K at $11.15 | Jun 30, 26 |
Ben Arye Barak Officer | Acquired (grant/award) | +1K | added 0.5% | 244K | $14K at $11.15 | Jun 30, 26 |
Leonard Frank X Officer | Acquired (grant/award) | +2K | added 0.4% | 461K | $21K at $11.15 | Jun 30, 26 |
Puri Michal Nath Officer | Acquired (grant/award) | +2K | added 0.9% | 203K | $21K at $11.15 | Jun 30, 26 |
Leonard Frank X Officer | Sold (automatic/other) | -34K 0.03% of company | sold 6.9% | 460K | $615K at $17.93 | Jun 4, 26 |
Vernon W Anthony Director | Acquired (grant/award) | +12K | added 5.9% | 209K | n/a | Jun 3, 26 |
Madden Martin J. Director | Acquired (grant/award) | +12K | added 62% | 30K | n/a | Jun 3, 26 |
Hung David Director | Acquired (grant/award) | +12K | added 57% | 32K | n/a | Jun 3, 26 |
Hilleman Jeryl L Director | Acquired (grant/award) | +12K | added 84% | 25K | n/a | Jun 3, 26 |
Scannell Timothy J Director | Acquired (grant/award) | +12K | added 81% | 26K | n/a | Jun 3, 26 |
Ocean Allyson J Director | Acquired (grant/award) | +12K | added 100% | 23K | n/a | Jun 3, 26 |
Stafford Kristin Director | Acquired (grant/award) | +12K | added 100% | 23K | n/a | Jun 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
Here is the latest on NVCR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NVCR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NVCR last traded at $14.94, down 6.16% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
NovoCure Limited Ordinary Shares (NVCR) is next expected to report earnings on Thursday, October 29, 2026 (before open), about 25 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NVCR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NVCR 46 times in the last 30 days.
NVCR (NovoCure Limited Ordinary Shares) trades on XNAS, with a market cap of about $1.74B in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NVCR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NVCR discussion
Sign in to ask a question or join the discussion.